Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-106976
Filing Date
2024-09-16
Accepted
2024-09-16 20:50:10
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6580
  Complete submission text file 0000950170-24-106976.txt   8253
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Scots-Knight Denise (Reporting) CIK: 0001297000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 241302333

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)